Physician profile
Jeffrey Meyer Collier
NPI 1942283833
$2,053.10
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $359 · 2020: $86.63 · 2021: $466 · 2022: $616 · 2023: $404 · 2024: $121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $525.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $525.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $588.83 | 2021-2024 | Vraylar, Qulipta |
| Novo Nordisk INC | $411.29 | 2019-2024 | Wegovy, Ozempic, Rybelsus |
| Lilly USA, LLC | $325.35 | 2020-2024 | Jardiance, Emgality, Mounjaro |
| Takeda Pharmaceuticals U.S.A., INC. | $104.35 | 2019-2024 | Trintellix |
| Bayer Healthcare Pharmaceuticals INC. | $89.62 | 2022-2023 | |
| Exact Sciences Corporation | $59.15 | 2023-2024 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $43.60 | 2019-2024 | Farxiga |
| Abbott Laboratories | $43.23 | 2022 | |
| Astellas Pharma US INC | $40.36 | 2019-2023 | Veozah |
| Amarin Pharma, INC. | $38.61 | 2019 | |
| Sanofi-Aventis U.S. LLC | $30.91 | 2021-2022 | |
| Ironshore Pharmaceuticals INC. | $29.21 | 2022-2023 | Jornay Pm |
| Nestle Healthcare Nutrition INC. | $28.80 | 2022-2023 | |
| Horizon Therapeutics Plc | $28.27 | 2021-2022 | |
| Shire North American Group INC | $27.62 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $27.51 | 2023 | |
| Glaxosmithkline, LLC. | $25.26 | 2021 | |
| Allergan, INC. | $25.19 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $23.06 | 2019 | |
| Adlon Therapeutics L.P. | $20.40 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.08 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $12.97 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $12.43 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Collier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.